Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

这种信号通路由蛋白GP130 介导，在细胞通讯中发挥核心作用，并影响转录因子 STAT3 的活性，而 STAT3 又与肿瘤的发展和扩散有关。因此，阻断 GP130 信号通路目前被视为癌症医学的一大希望。

"We’re finding that plant-derived substances may one day be used to support traditional cancer treatment and prevention ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it ...

14, 2024 — Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell ...